Former minister Malusi Gigaba has denied the allegations made by a witness at the Zondo commission.The unnamed witness said on Thursday that Gigaba went on a suit shopping spree in Sandton after going to the Gupta compound.Gigaba says he wants to cross-examine the witness.Former finance minister Malusi Gigaba has denied allegations heard at the Zondo…
Norma Gigaba. Ziyaad Douglas, Gallo Images Norma Gigaba, who has been charged with malicious damage to property and crimen injuria, will approach the High Court to challenge her arrest. Gigaba, the wife of former finance minister Malusi Gigaba, briefly appeared in the Hatfield Magistrate's Court in Pretoria on Monday morning. She is being represented by advocates Dali…
Norma Gigaba on the red carpet at the State of the Nation Address 2018. (Photo by Gallo Images / Ziyaad Douglas) Former minister Malusi Gigaba's wife, Norma, spent Friday night locked in police cells after her arrest at their Waterkloof home.She secured her freedom today, after paying bail.Next, she faces three criminal charges in court…
Malusi Gigaba. Esa Alexander, Gallo Images Malusi Gigaba still believes he has a future in the ANC.In a radio interview on Thursday, he blamed ANC leaders for the Fireblade saga that led him to getting axed. Gigaba says some senior leaders in government could have cleared up the confusion. "I still have a future in the ANC…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.